North Brunswick, NJ, United States of America

Matthieu Barrague

This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Sanofi, Celgene Car LLC, Aventis Pharmaceuticals Inc.. Active years: 2009-2020.

USPTO Granted Patents = 11 

% Patents Active = 63.6

 

 

Average Co-Inventor Count = 11.7

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Hoboken, NJ (US) (2009)
  • Union City, NJ (US) (2010)
  • Bridgewater, NJ (US) (2013)
  • North Brunswick, NJ (US) (2011 - 2020)

Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Matthieu Barrague - Innovative Inventor from North Brunswick

Introduction: Matthieu Barrague is a talented inventor hailing from North Brunswick, NJ. His passion for innovation and problem-solving has led to remarkable contributions in various fields.

Latest Patents: Matthieu Barrague holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes.

Career Highlights: With a background in engineering and a keen eye for detail, Barrague has successfully developed cutting-edge solutions that have garnered attention in the industry. His commitment to pushing the boundaries of technology is evident in his impressive portfolio of inventions.

Collaborations: Throughout his career, Matthieu Barrague has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His ability to work in multidisciplinary teams has resulted in groundbreaking innovations with real-world applications.

Conclusion: Matthieu Barrague's dedication to innovation and his relentless pursuit of excellence make him a standout figure in the world of inventors. His work continues to inspire and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…